Companion-animal care
Research questions around severe anemia, blood loss and practical oxygen-delivery support in dogs, cats and other companion animals.
Veterinary Applications
Veterinary oxygen carrier applications.
BHOC is a development direction in precision oxygen therapeutics for settings where anemia or blood loss limits oxygen-carrying capacity.
Research direction
Where the veterinary questions begin.
Emergency oxygen support
Time-sensitive veterinary settings where donor blood may be delayed, unavailable or operationally difficult to provide.
Wildlife medicine
Species-specific research challenges in conservation medicine, zoological care and remote field environments.
1998FDA veterinary precedent
Historical veterinary precedent
Oxyglobin and canine anemia.
In 1998, the FDA approved Oxyglobin, hemoglobin glutamer-200 (bovine), for anemia in dogs. This is a product-specific veterinary HBOC precedent.
The historical approval does not establish BHOC approval or suitability in other species. Each application requires its own evidence for dosing, safety and efficacy.
Historical canine use map
What historical canine use mapped out.
Biopure's historical booklet reports 885 manufacturer-collected veterinary submissions from 1998-1999 and prints 146 selected canine case vignettes. It is a descriptive dog-only archive, separate from the controlled FDA trial.
Emergency blood loss and trauma
Historically reported as immediate oxygen-carrying support while bleeding control, diagnostics or surgery addressed the cause.
Perioperative anemia and hemorrhage
Historically reported before, during or after surgery when rapid oxygen-delivery support was clinically important.
Hemolysis and regenerative anemia
Historically reported as a bridge while disease-specific treatment acted; the archive also records deaths and later complications.
Ineffective erythropoiesis
Historically reported in renal, marrow and neoplastic disease, with mixed and often short follow-up.
Historical manufacturer-collected reports. Canine, product-specific and descriptive. They do not establish BHOC efficacy, approval in another species or current Oxyglobin availability.
Evidence navigation
Continue into the veterinary evidence.
Use Science & Research Questions for guided interpretation, or open the Evidence & Cases library for source-linked publications, cases and regulatory records.
Research and partnerships
Contact our teamDiscuss a veterinary research collaboration.
For research, conservation and strategic partnerships, contact BHOC Therapeutics.
Species, donor access and research routes
Follow the care question to its evidence: donor access and compatibility, historical product findings, or a defined veterinary research proposal.